All In MedTech

Device Trial Radar · NCT06098937

Kalifilcon A Toric Compared to Commercially Available Lenses

Orientation Characteristics of Kalifilcon A Daily Disposable Toric Contact Lenses Compared to Commercially Available Daily Disposable Toric Contact Lenses

Last checked: Nov 20, 2026Latest source record: Dec 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

30

Actual

Start

Sep 5, 2023

Primary completion

Sep 27, 2023

Study completion Sep 27, 2023

Sponsor

Lead sponsor
Bausch & Lomb IncorporatedNot on our public-company list
Sponsor type
Industry
First posted
Oct 25, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Approximately thirty contact lens adapted subjects will be enrolled in this feasibility, bilateral, randomized, double masked (subject and investigator masked), repeated measures insertion study.

Conditions

  • Astigmatism

Interventions

  • Kalifilcon Toric LensDevice

    Kalifilcon A Daily Disposable Toric for Ametropia

  • Total1 for AstigmatismDevice

    Total1 for Astigmatism

  • Precision1 for AstigmatismDevice

    Precision1 for Astigmatism

  • MyDay ToricDevice

    MyDay Toric

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Gaze Orientation for 5 MinutesTime frame: 5 minutes after lens insertion

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Bausch & Lomb, Incorporated

    Rochester, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.